Relapsed/Refractory Lymphoma

Explore clinical trials studying Relapsed/Refractory Lymphoma. Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory Lymphoma trial results

Recruiting

NCT06756321

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Affiliated Hospital of Nantong University Nantong, Jiangsu, China

Recruiting

NCT06532643

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China

Completed

NCT05189093

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Cancer Hospital Chinese Academy of Medical Sciense Beijing, Beijing Municipality, China

Completed

NCT05713110

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

Completed

NCT02259010

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: St Louis, Missouri, United States

Oklahoma City, Oklahoma, United States

Germantown, Tennessee, United States

Dallas, Texas, United States

Completed

NCT02214147

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Miami, Florida, United States

Chicago, Illinois, United States

Ann Arbor, Michigan, United States

St Louis, Missouri, United States